tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christoph Gretler, 14 are a HOLD (70%), 6 are a BUY (30%).
Analyst Christoph Gretler, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 45% that have a potential upside of 16.7% achieved within 196 days.
Christoph Gretler’s has documented 38 price targets and ratings displayed on 5 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 07-Aug-2023.
Analyst best performing recommendations are on SNN (SMITH & NEPHEW SNATS).
The best stock recommendation documented was for SNN (SMITH & NEPHEW SNATS) at 2/24/2022. The price target of $20.79 was fulfilled within 214 days with a profit of $10.69 (33.96%) receiving and performance score of 1.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
1 months 10 days ago
(01-Sep-2025)
1/2 (50%)
$22.24 (122.81%)
917
Hold
$30
$3.18 (11.86%)
$25
5 months ago
(11-May-2025)
9/14 (64.29%)
$2.64 (9.65%)
325
Sell
5 months 20 days ago
(21-Apr-2025)
0/5 (0%)
$23.43 (140.38%)
Hold
$85.26
8 months 14 days ago
(27-Jan-2025)
0/3 (0%)
$49.25 (136.77%)
Sell
11 months 6 days ago
(05-Nov-2024)
3/15 (20%)
$13.36 (81.07%)
154
What Year was the first public recommendation made by Christoph Gretler?
